QUANTUM GENOMICS

Insiders Quantum Genomics Deutsche Boerse AG

Equities

2QG

FR0011648971

Market Closed - Deutsche Boerse AG Other stock markets 08:18:13 17/05/2024 BST			5-day change	1st Jan Change
0.1204 ^EUR	+0.67%		-1.47%	+36.82%

03-13	Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Quantum Genomics Ousts Board President; CEO Named Successor	23/02/23	MT
Quantum Genomics Announces the Appointment of Its New Scientific Advisory Board	27/06/22	CI
Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs	04/05/22	CI
Stéphane Cohen Joins Quantum Genomics as Director of Global Operations	14/03/22	CI
Quantum Genomics Société Anonyme Announces Resignation of Jean-Paul Kress from the Board	27/06/19	CI
Quantum Genomics Appoints Frans Leenen as Scientific Advisory Board	05/02/18	CI
Quantum Genomics Establishes U.S. Clinical Advisory Board; Announces Plans to Open U.S. Office	03/02/16	CI
Quantum Genomics Announces the Appointment of Dr. Olivier Madonna as Chief Medical Officer	27/11/14	CI
Quantum Genomics Announces Management Changes	15/05/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer